Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Divi's Laboratories Limited, widely recognised as Divis Laboratories or Divi's Lab, is a prominent pharmaceutical company headquartered in Hyderabad, India. Founded in 1990, it has evolved into a global leader in the pharmaceutical sector, leveraging over three decades of operational excellence.
Specialising in pharmaceutical research and development services, Divis excels in the large-scale manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical Ingredients. Its core offering includes custom synthesis for global pharmaceutical companies, distinguished by high-quality, cost-effective production and robust R&D capabilities.
+26 vs industry average
Divis Laboratories’s score of 59 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Divi's Laboratories Limited, an India-based company in the Research and development services industry, reported total Scope 1, 2, and 3 emissions of approximately 1.95 billion kg CO2e in 2026. This figure includes about 371.7 million kg CO2e from Scope 1, 378.5 million kg CO2e from Scope 2, and 1.20 billion kg CO2e from Scope 3.
In 2025, the company's total Scope 1, 2, and 3 emissions were approximately 1.59 billion kg CO2e, comprising about 339.9 million kg CO2e from Scope 1, 357.8 million kg CO2e from Scope 2, and 897.0 million kg CO2e from Scope 3. For 2024, Divi's Laboratories Limited reported total Scope 1, 2, and 3 emissions of approximately 1.52 billion kg CO2e, with Scope 1 emissions at about 363.2 million kg CO2e, Scope 2 emissions at around 326.0 million kg CO2e, and Scope 3 emissions at about 832.2 million kg CO2e.
Looking further back, in 2023, the company reported approximately 380.7 million kg CO2e in Scope 1 emissions and 373.1 million kg CO2e in Scope 2 emissions, with Scope 3 data not available for that year. In 2022, Divi's Laboratories Limited reported Scope 1 emissions of approximately 382.7 million kg CO2e and Scope 2 emissions of around 370.7 million kg CO2e, with Scope 3 data also not available.
Divi's Laboratories Limited has set Science Based Targets initiative (SBTi) approved targets. The company commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-term targets include reducing absolute Scope 1 and 2 GHG emissions by 58.8% by FY2034 from a FY2024 base year, and reducing absolute Scope 3 GHG emissions by 35% within the same timeframe. Long-term net-zero targets commit to reducing absolute Scope 1 and 2 GHG emissions by 90% by FY2050 from a FY2024 base year, and reducing absolute Scope 3 GHG emissions by 90% within the same timeframe. These targets cover greenhouse gas emissions from company operations (Scope 1 and 2) and are consistent with reductions required to keep warming to 1.5°C. The target boundary includes land-related emissions and removals from bioenergy feedstocks. Additionally, the company aims to reduce intensity-based Scope 1 and Scope 2 GHG emissions by 25% between 2023 and 2030.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Divis Laboratories’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more